Mark For: MACDX® trademark registration is intended to cover the category of
Website | www.visionperformance.store |
Research | OneLook Acronym Finder |
Serial Number | 90634349 |
Registration Number | 6771223 |
Mark Literal Elements | MACDX |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2022-03-09 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Docket Number | 118256 |
2021-04-08 | Date of First Use |
2021-04-08 | Date of Use In Commerce |
2021-04-09 | Application Filed |
2021-04-13 | Location: NEW APPLICATION PROCESSING |
2021-04-13 | Status: Live/Pending |
2021-04-13 | Transaction Date |
2022-03-09 | Location: PUBLICATION AND ISSUE SECTION |
2022-04-12 | Published |
2022-04-12 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
2022-06-28 | Trademark Registered |
Party: | Hofeldt, Albert |
Address | www.visionperformance.store 11 ISLAND AVE, APT 1001 Miami Beach, FLORIDA UNITED STATES 33139 |
Legal Entity Type | Individual |
Drawing | 2021-04-09 | |
Specimen | 2021-04-09 | |
TEAS Plus New Application | 2021-04-09 | |
Offc Action Outgoing | 2021-11-30 | |
XSearch Search Summary | 2021-11-30 | |
Response to Office Action | 2022-03-07 | |
Specimen | 2022-03-07 | |
Amendment and Mail Process Complete | 2022-03-10 | |
Publication & Issue Review Complete | 2022-03-10 | |
TRAM Snapshot of App at Pub for Oppostn | 2022-03-10 | |
Notice of Publication | 2022-03-23 | |
Notification Of Notice of Publication | 2022-03-23 | |
OG Publication Confirmation | 2022-04-12 |
IC 010. US 026 039 044. G & S: Medical diagnostic apparatus for testing retinal function. FIRST USE: 20210408. FIRST USE IN COMMERCE: 20210408
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0101 | Medical diagnostic apparatus for testing retinal function |
GS0101 | Medical diagnostic apparatus for testing retinal function |
Description | Date | Proceeding Number |
---|---|---|
PUBLISHED FOR OPPOSITION | 2022-04-12 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-04-12 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-03-23 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-03-09 | 96338 |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2022-03-09 | 96338 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-03-09 | 96338 |
ASSIGNED TO LIE | 2022-03-09 | 96338 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-03-09 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-03-07 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-11-30 | 6325 |
NON-FINAL ACTION WRITTEN | 2021-11-30 | 94351 |
NON-FINAL ACTION E-MAILED | 2021-11-30 | 6325 |
ASSIGNED TO EXAMINER | 2021-11-30 | 94351 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-07-16 | |
NEW APPLICATION ENTERED IN TRAM | 2021-04-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.